Syncope
For patient information click here
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Sahar Memar Montazerin, M.D.[2] Sara Zand, M.D.[3]
Synonyms and keywords: Vasovagal syncope; Neurally mediated syncope; Common faint; Vasodepressor syncope; Neurocardiogenic syncope
Overview
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Sara Zand, M.D.[2] Sahar Memar Montazerin, M.D.[3]
Overview
Syncope is defined as abrupt, transient complete loss of consciousness, inability to keep postural tone, rapid spontaneous recovery with the mechanism of cerebral hypoperfusion. Syncope is usually classified based on the underlying mechanisms leading to hypoperfusion. Syncope is classified to reflex-mediated, orthostatic hypotension, and cardiovascular and syncope of unknown origin subtypes. Neurally mediated syncope (common faint) is the most common type of reflex syncope in younger patients occurs during upright position ( standing , sitting) with prodrome symptoms including diaphoresis, warmth, nausea, and pallor, usually after emotional stress, pain, medical setting. Orthostasis hypotension is defined as reduction in systolic blood pressure of ≥20 mmHg or diastolic blood pressure of ≥10 mm Hg within 3 minutes of standing position and is common in older patients. Carotid sinus syndrome is a type of reflex syncope due to carotid sinus hypersensitivity defined as pause ≥3 seconds and/or a reduction of systolic blood pressure ≥50 mm Hg during stimulation of the carotid sinus, and is more common in older patients. Taking history and [[physical examination] may helpful for the diagnosis. There are some conditions that are incorrectly diagnosed as syncope. These conditions are usually associated with partial or complete loss of consciousness such as epilepsy, metabolic disorders, transient ischemic attack or conditions with loss of posture and without loss of consciousness like cataplexy, drop attacks, falls and pseudo-syncope.There is limited information about the historical perspective of syncope.There are several pathways to explain its pathophysiology, depending on if it is either reflex syncope, orthostatic intolerance, or cardiovascular syncope. Peripheral vascular resistance and cardiac output are the two main determinants for the presentation of syncope. autonomic nervous system impairment due to drugs or an autonomic failure, can lead to a decrease in peripheral vascular resistance. Reflex activity impairment may also cause a decrease of peripheral vascular resistance, as the body normal compensation reflexes fail. Decrease in cardiac output may be due to venous pooling, cardioinhibitory reflexes, arrhythmia, hypertension, pulmonary embolism, and volume depletion leading to diminished venous return, among others. Syncope should be differentiated from other conditions causing partial or complete loss of consciousness. These disorders may include, coma, dizziness, seizure, and vertigo. There are conditions that may mistakenly be diagnosed as syncope. These conditions include epilepsy, hypoglycemia, intoxication, cataplexy, and transient ischemic attacks. The incidence of syncope ranges from 260 to 1950 cases per 100,000 individuals worldwide. It increases with age and especially after age 70 years old. Syncope affects men and women equally. Syncope is a sign of insufficient cerebral blood flow and it should be evaluated for the underlying cause. Possible underlying risk factors of cardiac syncope include Older age (>60 y), male sex, presence of known ischemic heart disease, structural heart disease, previous arrhythmias, or reduced ventricular function, brief prodromes such as palpitations or sudden loss of consciousness without a prodrome, syncope during exertion, syncope in the supine position, low number of syncope episodes (1 or 2), abnormal cardiac examination, family history of inheritable conditions or premature sudden cardiac death (SCD) (<50 y of age), Presence of known congenital heart disease. Common risk factors associated with noncardiac causes of syncope include younger age, no known cardiac disease, syncope only in the standing position, positional change from supine or sitting to standing, presence of prodrome: nausea, vomiting, feeling warm, presence of specific triggers ||||( dehydration, pain, stressful stimulus, medical environment), situational triggers( cough, laugh, micturition, defecation, deglutition), history of syncope with similar characteristics and frequent recurrence.Patients with syncope are at risk of the development of complications, such as trauma from frequent falls and Sudden cardiac death. The prognosis of syncope depends on underlying causes. Syncope caused by cardiovascular diseases may be life-threatening and is an important cause of sudden cardiac death. Prognosis of vasovagal syncope is favorable. Syncope itself is a symptom. Patients with syncope may feel balcking out, dizziness, lightheadedness, and temporary loss of consciousness. Patients may experience other symptoms based on the underlying causes of the syncope.Patients with syncope usually appear normal. Physical examination of patients with syncope is usually remarkable for cardiac murmur, orthostatic hypotension, and altered level of consciousness during the episode of syncope.There are no diagnostic laboratory findings associated with syncope. Some patients with syncope may have acidosis, which is usually suggestive of insufficient blood flow. Other possible laboratory findings may include hypoglycemia, increased lactate level, hypoxia, and hypercapnia. Generally, the ECG of individuals with syncope is normal. However, ECG may be remarkable for an arrhythmia. The arrhythmia may be seen on the EKG include sinus bradycardia <40 beats/min or repetitive sinoatrial blocks or sinus pauses > 3s, Mobitz II 2nd or 3rd-degree atrioventricular block, alternating left and right bundle branch block, rapid paroxysmal supraventricular tachycardia, ventricular tachycardia, and pacemaker malfunction with cardiac pauses.CXR is necessary for evaluation of patients presented with syncope and abnormal findings may be suggestive of adverse event. Transthoracic echocardiography can be useful in the diagnostic workup of patients presenting with syncope. This evaluation is especially warranted in patients who are suspected to have structural heart disease. CT scan is useful when other modalities are inconclusive for evaluation of structural heart disease in the presence of syncope.If syncope is suspected due to pulmonary thromboembolism CT scan is recommended. Cardiac MRI can be useful in the presence of syncope and suspected structural or infiltrative heart disease such as arrhythmogenic right ventricular dysplasia or cardiac sarcoidosis. Other diagnostic studies for syncope include tilt table test and Exercise Stress Test. Tilt table test is especially useful in differentiating syncope from other possible causes of transient loss of consciousness, such as epilepsy and conversion disorder. A tilt table test can help to reveal Vasovagal syncope or hypotensive syncope. The patient is on the table is tilted at 70 degrees for 45 minutes. A positive test is defined induced hypotension with or without bradycardia or asystole suggestive of vasovagal syncope. If hypotension occurs within the first 3 minutes of test orthostasis hypotension is concerned. In delay orthostasis hypotension fall in blood pressure occurs after 3 minutes. Exercise stress test (EST) is recommended in the presence of syncope during exercise or syncope during the occurrence of angina pectori suspected myocardial ischemia. Contraindications for EST in patients with syncope include: hypertrophic obstructive cardiomyopathy, severe aortic stenosis,Catecholaminegic polymorphic ventricular tachycardia(CPVT), pulmonary artery hepertension,Interarterial anomalous coronary artery ,Long QT syndrome type 1. Medical therapy is the mainstay of the treatment based on the cause and mechanism of syncope for preventing syncope recurrences and traumatic injuries and prolong survival. All patients with cardiac syncope should be hospitalized. If the machanism of syncope is bifascicular block, permanent pacemaker is recommended. In the setting of inferior myocardial infarction and complete heart block, implantation of permanent pacemaker is not the first decision and the best approach is treatment of myocardial infarction. In syncope secondary to documented VT, VF due to structural heart disease such as ischemic and non-ischemic cardiomyopathy and decreased left ventricular ejection fraction treatment of arrhythmia and ICD implantation is warranted. In VT secondary to sarcoidosis and frequent syncope due to reentry arrhythmia loop around the granulom formation in myocardium, ICD implantation is necessary. In inherent causes of ventricular tachyarrhythmia such as Long QT syndrome, Short QT syndrome, Brugada, Cathecolaminegic polymorphic ventricular tachycardia (CPVT), Arrhythmogenic right ventricular dysplasia(ARVC) making decision for ICD implantation is associated with documented ventricular tachyarrhythmia. For other type of syncope increasing salt and discontinuation of causing medications and education of the patient is recommended. Patients with neurally mediated syncope should be educated about participate factors such as dehydration,prolong standing, alcohol,diuretic, vasodilators and sitting down or lie-down at the onset of symptoms and doing counterpressure maneuvers( hand gripping, leg crossing, arm tensing). Medications may be helpful in neurally mediated syncope include betablocker,midoderine, SSRI. Ingestion of 500 cc water acutely prevents hypotensive syncope. Some of the measures that can be taken to prevent vasovagal syncopal episodes include avoidance of prolonged standing, hot environment, humid atmosphere. Secondary prevention strategies following syncope include ICD implantation in ventricular arrhythmia and avoidance of driving for a specific time based on the guideline.
Historical Perspective
There is limited information about the historical perspective of syncope.
Classification
Syncope is defined as abrupt, transient complete loss of consciousness, inability to keep postural tone, rapid spontaneous recovery with the mechanism of cerebral hypoperfusion. Syncope is usually classified based on the underlying mechanisms leading to hypoperfusion. Syncope is classified to reflex-mediated, orthostatic hypotension, and cardiovascular subtypes. Neurally mediated syncope (common faint) is the most common type of reflex syncope in younger patients occurs during upright position ( standing , sitting) with prodrome symptoms including diaphoresis, warmth, nausea, and pallor, usually after emotional stress, pain, medical setting. Orthostasis hypotension is defined as reduction in systolic blood pressure of ≥20 mmHg or diastolic blood pressure of ≥10 mm Hg within 3 minutes of standing position and is common in older patients. Carotid sinus syndrome is a type of reflex syncope due to carotid sinus hypersensitivity defined as pause ≥3 seconds and/or a reduction of systolic blood pressure ≥50 mm Hg during stimulation of the carotid sinus is more common in older patients. Taking history and physical examination may helpful for the diagnosis. There are some conditions that are incorrectly diagnosed as syncope. These conditions are usually associated with partial or complete loss of consciousness such as epilepsy, metabolic disorders, transient ischemic attack or conditions with loss of posture and without loss of consciousness like cataplexy, drop attacks, falls and pseudo-syncope.
Pathophysiology
Syncope is an entity in which loss of conscience due to cerebral hypoperfusion presents. There are several pathways to explain its pathophysiology, depending on if it is either reflex syncope, orthostatic intolerance, or cardiovascular syncope.
Causes
Peripheral vascular resistance and cardiac output are the two main determinants for the presentation of syncope. autonomic nervous system impairment due to drugs or an autonomic failure, can lead to a decrease in peripheral vascular resistance. Reflex activity impairment may also cause a decrease of peripheral vascular resistance, as the body normal compensation reflexes fail. Decrease in cardiac output may be due to venous pooling, cardioinhibitory reflexes, arrhythmia, hypertension, pulmonary embolism, and volume depletion leading to diminished venous return, among others.
Differentiating Syncope from other Diseases
Syncope should be differentiated from other conditions causing partial or complete loss of consciousness. These disorders may include, coma, dizziness, seizure, and vertigo. There are conditions that may mistakenly be diagnosed as syncope. These conditions include epilepsy, hypoglycemia, intoxication, cataplexy, and transient ischemic attacks.
Epidemiology and Demographics
The incidence of syncope ranges from 260 to 1950 cases per 100,000 individuals worldwide. It increases with age and especially after age 70 years old. Syncope affects men and women equally.
Risk Factors
Syncope is a sign of insufficient cerebral blood flow and it should be evaluated for the underlying cause. Possible underlying risk factors of cardiac syncope include Older age (>60 y), male sex, presence of known ischemic heart disease, structural heart disease, previous arrhythmias, or reduced ventricular function, brief prodromes such as palpitations or sudden loss of consciousness without a prodrome, syncope during exertion, syncope in the supine position, low number of syncope episodes (1 or 2), abnormal cardiac examination, family history of inheritable conditions or premature sudden cardiac death (SCD) (<50 y of age), Presence of known congenital heart disease. Common risk factors associated with noncardiac causes of syncope include younger age, no known cardiac disease, syncope only in the standing position, positional change from supine or sitting to standing, presence of prodrome: nausea, vomiting, feeling warm, presence of specific triggers ||||( dehydration, pain, stressful stimulus, medical environment), situational triggers( cough, laugh, micturition, defecation, deglutition), history of syncope with similar characteristics and frequent recurrence.
Natural History, Complications, and Prognosis
Patients with syncope are at risk of the development of complications, such as trauma from frequent falls and Sudden cardiac death. The prognosis of syncope depends on underlying causes. Syncope caused by cardiovascular diseases may be life-threatening and is an important cause of sudden cardiac death. Prognosis of vasovagal syncope is favorable.
Diagnosis
History and Symptoms
Syncope itself is a symptom. Patients with syncope may feel balcking out, dizziness, lightheadedness, and temporary loss of consciousness. Patients may experience other symptoms based on the underlying causes of the syncope.
Physical Examination
Patients with syncope usually appear normal. Physical examination of patients with syncope is usually remarkable for cardiac murmur, orthostatic hypotension, and altered level of consciousness.
Laboratory Findings
There are no diagnostic laboratory findings associated with syncope. Some patients with syncope may have acidosis, which is usually suggestive of insufficient blood flow. Other possible laboratory findings may include hypoglycemia, increased lactate level, hypoxia, and hypercapnia.
Electrocardiogram
Generally, the ECG of individuals with syncope is normal. However, ECG may be remarkable for an arrhythmia. The arrhythmia may be seen on the EKG include sinus bradycardia <40 beats/min or repetitive sinoatrial blocks or sinus pauses > 3s, Mobitz II 2nd or 3rd-degree atrioventricular block, alternating left and right bundle branch block, rapid paroxysmal supraventricular tachycardia, ventricular tachycardia, and pacemaker malfunction with cardiac pauses.
X-ray
CXR is necessary for evaluation of patients presented with syncope and abnormal findings may be suggestive of adverse event.
CT
CT scan is useful when other modalities are inconclusive for evaluation of structural heart disease in the presence of syncope.(Class2b, 2017AHA/ACC/HRS guideline). If syncope is suspected due to pulmonary thromboembolism CT scan is recommended.
MRI
Cardiac MRI can be useful in the presence of syncope and suspected structural or infiltrative heart disease such as arrhythmogenic right ventricular dysplasia or cardiac sarcoidosis.
Echocardiography
Transthoracic echocardiography can be useful in the diagnostic workup of patients presenting with syncope. This evaluation is especially warranted in patients who are suspected to have structural heart disease.
Other Diagnostic Studies
There are no other imaging findings associated with syncope.
Other Diagnostic Studies
Other diagnostic studies for syncope include tilt table test and Exercise Stress Test. Tilt table test is especially useful in differentiating syncope from other possible causes of transient loss of consciousness, such as epilepsy and conversion disorder. A tilt table test can help to reveal Vasovagal syncope or hypotensive syncope. The patient is on the table is tilted at 70 degrees for 45 minutes. A positive test is defined induced hypotension with or without bradycardia or asystoe suggestive of vasovagal syncope. If hypotension occurs within the first 3 minutes of test orthostasis hypotension is concerned. In delay orthostasis hypotension fall in blood pressure occurs after 3 minutes. Exercise stress test (EST) is recommended in the presence of syncope during exercise or syncope during the occurrence of angina pectori suspected myocardial ischemia. Contraindications for EST in patients with syncope include: hypertrophic obstructive cardiomyopathy, severe aortic stenosis,Catecholaminegic polymorphic ventricular tachycardia(CPVT), pulmonary artery hepertension,Interarterial anomalous coronary artery ,Long QT syndrome type 1.
Treatment
Medical Therapy
Medical therapy is the mainstay of the treatment based on the cause and mechanism of syncope for preventing syncope recurrences and traumatic injuries and prolong survival. All patients with cardiac syncope should be hospitalized. If the machanism of syncope is bifascicular block, permanent pacemaker is recommended. In the setting of inferior myocardial infarction and complete heart block, implantation of permanent pacemaker is not the first decision and the best approach is treatment of myocardial infarction. In syncope secondary to documented VT, VF due to structural heart disease such as ischemic and non-ischemic cardiomyopathy and decreased left ventricular ejection fraction treatment of arrhythmia and ICD implantation is warranted. In VT secondary to sarcoidosis and frequent syncope due to reentry arrhythmia loop around the granulom formation in myocardium, ICD implantation is necessary. In inherent causes of ventricular tachyarrhythmia such as Long QT syndrome, Short QT syndrome, Brugada, Cathecolaminegic polymorphic ventricular tachycardia (CPVT), Arrhythmogenic right ventricular dysplasia(ARVC) making decision for ICD implantation is associated with documented ventricular tachyarrhythmia. For other type of syncope increasing salt and discontinuation of causing medications and education of the patient is recommended. Patients with neurally mediated syncope should be educated about participate factors such as dehydration,prolong standing, alcohol,diuretic, vasodilators and sitting down or lie-down at the onset of symptoms and doing counterpressure maneuvers( hand gripping, leg crossing, arm tensing). Medications may be helpful in neurally mediated syncope include betablocker,midoderine, SSRI.
Surgery
Surgical intervention is not recommended for the management of syncope.
Primary Prevention
Some of the measures that can be taken to prevent vasovagal syncopal episodes include avoidance of prolonged standing, hot environment, humid atmosphere.
Secondary Prevention
Secondary prevention strategies following syncope include ICD implantation in ventricular arrhythmia and avoidance of driving for a specific time based on the guideline.
Historical Perspective
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief:
Overview
There is limited information about the historical perspective of syncope.
Historical Perspective
Discovery
- There is limited information about the historical perspective of syncope.
Classification
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]: Associate Editor(s)-in-Chief: Sahar Memar Montazerin, M.D.[2] Sara Zand, M.D.[3]
Overview
Syncope is defined as abrupt, transient complete loss of consciousness, inability to keep postural tone, rapid spontaneous recovery with the mechanism of cerebral hypoperfusion. Syncope is usually classified based on the underlying mechanisms leading to hypoperfusion. Syncope is classified to reflex-mediated, orthostatic hypotension, and cardiovascular subtypes. Neurally-mediated syncope (common faint) is the most common type of reflex syncope in younger patients occurs during upright position (standing, sitting) with prodrome symptoms including diaphoresis, warmth, nausea, and pallor, usually after emotional stress, pain, medical setting. Orthostasis hypotension is explained as reduction in systolic blood pressure of ≥20 mmHg or diastolic blood pressure of ≥10 mm Hg within 3 minutes of standing position and is common in older patients. Carotid sinus syndrome which is a type of reflex syncope due to carotid sinus hypersensitivity is defined as pause ≥3 seconds and/or a reduction of systolic blood pressure ≥50 mm Hg during stimulation of the carotid sinus and is more common in older patients. There are some conditions that are incorrectly diagnosed as syncope. These conditions are usually associated with partial or complete loss of consciousness such as epilepsy, metabolic disorders, transient ischemic attack or conditions with loss of posture and without loss of consciousness like cataplexy, drop attacks, falls and pseudo-syncope.
Classification
Syncope is usually classified based on the underlying mechanisms leading to cerebral hypoperfusion. According to 2017AHA/ACC/HRS guideline, syncope is classified to:[1]
| Terms | Definition |
|---|---|
| Syncope | Abrupt, transient complete loss of consciousness, inability to keep postural tone, rapid spontaneous recovery with the mechanism of cerebral hypoperfusion |
| Pre syncope, near syncope | The symptoms before syncope including lightheadedness, visual sensations, such as tunnel vision or graying out, variable degrees of altered consciousness without complete loss of consciousness |
| Unexplained syncope | Undetermined etiology after initial evaluation including history, physical examination, ECG |
| Orthostatic intolerance | Frequent, recurrent, or persistent lightheadedness, palpitations, tremulous, generalized weakness, blurred vision, exercise intolerance, fatigue upon standing. These symptoms happen with or without orthostasis tachycardia, orthostasis intolerance or syncope. Patients have more than one symptoms with inability to maintain standing posture. |
| Orthostatic tachycardia | Increasing heart rate ≥30 bpm within 10 minutes after standing (without exercise) from recumbent position oror ≥40 bpm in individuals 12–19 year of age |
| Orthostatic hypotension | Decreasing systolic blood pressure of ≥20 mmHg or diastolic blood pressure of ≥10 mm Hg in standing position |
| Initial (immediate) orthostatic hypotension | A transient reduction in blood pressure within 15 seconds after standing accompanied by syncope or presyncope |
| Classic orthostatic hypotension | A sustain reduction in systolic blood pressure of ≥20 mmHg or diastolic blood pressure of ≥10 mm Hg within 3 minutes of standing position |
| Delayed orthostatic hypotension | A sustain reduction in systolic blood pressure of ≥20 mmHg (or 30 mm Hg in patients with supine hypertension) or diastolic blood pressure of ≥10 mm Hg after 3 minutes of standing position |
| Neurogenic hypotension | A subtype of orthostasis hypotension due to central or peripheral autonomic nervous system dysfunction |
| Cardiac syncope | tachyarrhythmia, bradyarhythmia, hypotension due to Low cardiac output state, valvular , bloodflow obstruction, vascular dissection, vasodilation leading syncope |
| Non cardiac syncope | reflex syncope, orthostatic hypotension, volume depletion, dehydration, blood loss |
| Reflex (neurally mediated) syncope | Syncope due to vasodilation, bradycardia or both |
| Vasovagal syncope | The most common type of reflex syncope mediated by vasovagal reflex during upright position( standing , sitting) presented with prodrome symptoms including diaphoresis, warmth, nausea, and pallor after emotional stress, pain, medical setting. Taking history and [[physical examination] and eyewitness may helpful for the diagnosis. |
| Carotid sinus syndrome | A type of reflex syncope due to carotid sinus hypersensitivity defined as pause ≥3 seconds and/or a reduction of systolic blood pressure ≥50 mm Hg during stimulation of the carotid sinus, more common in older patients |
| Situational syncope | A type of reflex syncope after specific physical functions such as coughing, laughing, swallowing, micturition, defecation |
| Postural orthostatic tachycardia syndrome (POTS) | an increase in heart rate of ≥30 bpm during a positional change from supine to standing (or ≥40 bpm in those 12–19 year of age) in the absence of orthostatic hypotension (>20 mm Hg reduction in systolic blood pressure). [[Heart rate> 120/ min in standing position and symptoms such as lightheadedness, palpitations, tremulousness, generalized weakness, blurred vision, exercise intolerance, and fatigue in standing position which are not related to specific functions ( bloating, nausea, diarrhea, abdominal pain. |
| Psychogenic pseudosyncope | False unconsciousness in the absent of cardiac, reflex, neurologic, metabolic causes |
There are some conditions that are incorrectly diagnosed as syncope. These conditions are usually associated with partial or complete loss of consciousness or with loss of posture and without loss of consciousness. The table below is one of the suggested classification systems for syncope:[2][3][4]
| Neurally-Mediated Syncope |
| Vasovagal |
|
|
| Situational |
|
|
|
|
| Carotid sinus syncope |
| Syncope due to Orthostatic Hypotension |
|---|
| Autonomic failure |
|
|
| Drug induced: |
| Volume depletion |
| Cardiovascular Syncope |
| Arrhythmia |
|
|
| Structural heart disease |
|
| Other cardiovascular: |
| Conditions Incorrectly Diagnosed as Syncope |
| Disorders with partial or complete loss of consciousness |
|
|
| Conditions without loss of consciousness |
|
|
|
| The above table adopted from ESC guideline |
|---|
References
- ↑ Shen, Win-Kuang; Sheldon, Robert S.; Benditt, David G.; Cohen, Mitchell I.; Forman, Daniel E.; Goldberger, Zachary D.; Grubb, Blair P.; Hamdan, Mohamed H.; Krahn, Andrew D.; Link, Mark S.; Olshansky, Brian; Raj, Satish R.; Sandhu, Roopinder Kaur; Sorajja, Dan; Sun, Benjamin C.; Yancy, Clyde W. (2017). “2017 ACC/AHA/HRS Guideline for the Evaluation and Management of Patients With Syncope: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society”. Circulation. 136 (5). doi:10.1161/CIR.0000000000000499. ISSN 0009-7322.
- ↑ Moya, A.; Sutton, R.; Ammirati, F.; Blanc, J.-J.; Brignole, M.; Dahm, J. B.; Deharo, J.-C.; Gajek, J.; Gjesdal, K.; Krahn, A.; Massin, M.; Pepi, M.; Pezawas, T.; Granell, R. R.; Sarasin, F.; Ungar, A.; van Dijk, J. G.; Walma, E. P.; Wieling, W.; Abe, H.; Benditt, D. G.; Decker, W. W.; Grubb, B. P.; Kaufmann, H.; Morillo, C.; Olshansky, B.; Parry, S. W.; Sheldon, R.; Shen, W. K.; Vahanian, A.; Auricchio, A.; Bax, J.; Ceconi, C.; Dean, V.; Filippatos, G.; Funck-Brentano, C.; Hobbs, R.; Kearney, P.; McDonagh, T.; McGregor, K.; Popescu, B. A.; Reiner, Z.; Sechtem, U.; Sirnes, P. A.; Tendera, M.; Vardas, P.; Widimsky, P.; Auricchio, A.; Acarturk, E.; Andreotti, F.; Asteggiano, R.; Bauersfeld, U.; Bellou, A.; Benetos, A.; Brandt, J.; Chung, M. K.; Cortelli, P.; Da Costa, A.; Extramiana, F.; Ferro, J.; Gorenek, B.; Hedman, A.; Hirsch, R.; Kaliska, G.; Kenny, R. A.; Kjeldsen, K. P.; Lampert, R.; Molgard, H.; Paju, R.; Puodziukynas, A.; Raviele, A.; Roman, P.; Scherer, M.; Schondorf, R.; Sicari, R.; Vanbrabant, P.; Wolpert, C.; Zamorano, J. L. (2009). “Guidelines for the diagnosis and management of syncope (version 2009): The Task Force for the Diagnosis and Management of Syncope of the European Society of Cardiology (ESC)”. European Heart Journal. 30 (21): 2631–2671. doi:10.1093/eurheartj/ehp298. ISSN 0195-668X.
- ↑ Sutton, Richard (2013). “Clinical Classification of Syncope”. Progress in Cardiovascular Diseases. 55 (4): 339–344. doi:10.1016/j.pcad.2012.11.005. ISSN 0033-0620.
- ↑ Puppala, Venkata Krishna; Dickinson, Oana; Benditt, David G. (2014). “Syncope: Classification and risk stratification”. Journal of Cardiology. 63 (3): 171–177. doi:10.1016/j.jjcc.2013.03.019. ISSN 0914-5087.
Pathophysiology
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Karol Gema Hernandez, M.D. [2] Sahar Memar Montazerin, M.D.[3]
Overview
Syncope is an entity in which loss of consciousness due to cerebral hypoperfusion presents. There are several pathways to explain its pathophysiology, depending on if it is either reflex syncope, orthostatic intolerance, or cardiovascular syncope.
Pathophysiology
Syncope is an entity in which loss of consciousness due to cerebral hypoperfusion presents. There are several pathways to explain its pathophysiology, depending on if it is either reflex syncope, orthostatic intolerance, or cardiovascular syncope.[1][2][3]
| Venous depletion/pooling | Arrhythmia or Structural heart disease | Vasodepressors/Cardioinhibitors | Drugs | Autonomic nervous failure | |||||||||||||||||||||||||||||||||||||||
| Inadequate venous return | Cardiac/Pulmonary cause | Inappropriate reflex | Normal ANS | Damaged ANS | |||||||||||||||||||||||||||||||||||||||
| Low cardiac output | Low cardiac output/Low peripheral resistance | Low peripheral resistance | |||||||||||||||||||||||||||||||||||||||||
| Cerebral hypoperfusion | |||||||||||||||||||||||||||||||||||||||||||
| Syncope | |||||||||||||||||||||||||||||||||||||||||||
Abbreviations: ANS: Autonomic nervous system
Reflex (Neurally-mediated) Syncope
Reflex syncope presents when there is a failure of the body’s normal compensation of cardiac reflexes in response to a trigger. It can be manifested as 4 categories, whose triggers differ:
- Vasovagal syncope
- Situational syncope
- Carotid sinus syncope
- Atypical forms
The table below provides information on the triggers of different subtypes of syncope:
| Syncope |
Triggers: |
| Vasovagal |
|
| Situational |
|
| Carotid Sinus |
|
| Atypical forms |
Orthostatic Intolerance
Orthostatic intolerance is caused by a chronic autonomic nervous system failure (ANF). ANF causes a deficient vasoconstriction and ultimately decreased blood pressure, leading to the manifestation of syncope.[4][5][6]
The table below compares different mechanisms of orthostatic hypotension.
| Classification |
Pathophysiology |
| Initial OH |
|
| Classic OH |
|
| Delayed/Progressive OH |
|
| Delayed Reflex syncope |
|
| Reflex syncope triggered by standing position |
|
| POTS (postural orthostatic tachycardia syndrome) |
|
Cardiovascular Syncope
- Cardiovascular syncope is the consequence of a decreased ability of the heart to pump blood and achieve adequate perfusion to all tissues.
- The brain is the main organ affected, causing cerebral hypoperfusion that leads to syncope.
- The main causes of cardiovascular syncope is due to arrhythmias and structural heart disease.
- Arrhythmia, the inadequate heart rate would cause a decrease in the synchronicity of the heart, consequently decreasing the perfusion of peripheral organs.
- In bradyarrhythmia, such as AV block, the heart decreases the contractions per minute, which leads to decrease perfusion of peripheral tissues. On the other hand, in tachyarrhythmia, the heart has not enough time to completely fill the ventricle and the ejection volume decreases, which also leads to decrease perfusion.
- In structural heart disease, an obstruction of the outflow (ex: aortic stenosis) would decrease the amount of blood reaching peripheral tissues and decrease the blood pressure. A myocardial infarction could also be the cause of syncope, an ischemic cardiac muscle could lead to an acute left ventricle dysfunction and decrease cerebral perfusion which causes loss of consciousness.
References
- ↑ Hainsworth, Roger (2004). “Pathophysiology of syncope”. Clinical Autonomic Research. 14 (S1): i18–i24. doi:10.1007/s10286-004-1004-2. ISSN 0959-9851.
- ↑ Moya, A.; Sutton, R.; Ammirati, F.; Blanc, J.-J.; Brignole, M.; Dahm, J. B.; Deharo, J.-C.; Gajek, J.; Gjesdal, K.; Krahn, A.; Massin, M.; Pepi, M.; Pezawas, T.; Granell, R. R.; Sarasin, F.; Ungar, A.; van Dijk, J. G.; Walma, E. P.; Wieling, W.; Abe, H.; Benditt, D. G.; Decker, W. W.; Grubb, B. P.; Kaufmann, H.; Morillo, C.; Olshansky, B.; Parry, S. W.; Sheldon, R.; Shen, W. K.; Vahanian, A.; Auricchio, A.; Bax, J.; Ceconi, C.; Dean, V.; Filippatos, G.; Funck-Brentano, C.; Hobbs, R.; Kearney, P.; McDonagh, T.; McGregor, K.; Popescu, B. A.; Reiner, Z.; Sechtem, U.; Sirnes, P. A.; Tendera, M.; Vardas, P.; Widimsky, P.; Auricchio, A.; Acarturk, E.; Andreotti, F.; Asteggiano, R.; Bauersfeld, U.; Bellou, A.; Benetos, A.; Brandt, J.; Chung, M. K.; Cortelli, P.; Da Costa, A.; Extramiana, F.; Ferro, J.; Gorenek, B.; Hedman, A.; Hirsch, R.; Kaliska, G.; Kenny, R. A.; Kjeldsen, K. P.; Lampert, R.; Molgard, H.; Paju, R.; Puodziukynas, A.; Raviele, A.; Roman, P.; Scherer, M.; Schondorf, R.; Sicari, R.; Vanbrabant, P.; Wolpert, C.; Zamorano, J. L. (2009). “Guidelines for the diagnosis and management of syncope (version 2009): The Task Force for the Diagnosis and Management of Syncope of the European Society of Cardiology (ESC)”. European Heart Journal. 30 (21): 2631–2671. doi:10.1093/eurheartj/ehp298. ISSN 0195-668X.
- ↑ . doi:10.1016/j.pcad.2012.10.01. Missing or empty
|title=(help) - ↑ Robertson, David (2008). “The pathophysiology and diagnosis of orthostatic hypotension”. Clinical Autonomic Research. 18 (S1): 2–7. doi:10.1007/s10286-007-1004-0. ISSN 0959-9851.
- ↑ Medow, Marvin S.; Stewart, Julian M.; Sanyal, Sanjukta; Mumtaz, Arif; Sica, Domenic; Frishman, William H. (2008). “Pathophysiology, Diagnosis, and Treatment of Orthostatic Hypotension and Vasovagal Syncope”. Cardiology in Review. 16 (1): 4–20. doi:10.1097/CRD.0b013e31815c8032. ISSN 1061-5377.
- ↑ Goldstein, David S.; Sharabi, Yehonatan (2009). “Neurogenic Orthostatic Hypotension”. Circulation. 119 (1): 139–146. doi:10.1161/CIRCULATIONAHA.108.805887. ISSN 0009-7322.
Causes
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Vendhan Ramanujam M.B.B.S [2] Sara Zand, M.D.[3]
Overview
Peripheral vascular resistance and cardiac output are the two main determinants for the presentation of syncope. autonomic nervous system impairment due to drugs or an autonomic failure, can lead to a decrease in peripheral vascular resistance. Reflex activity impairment may also cause a decrease of peripheral vascular resistance, as the body normal compensation reflexes fail. The decrease in cardiac output may be due to venous pooling, cardioinhibitory reflexes, arrhythmia, pulmonary embolism, and volume depletion leading to diminished venous return, among others.
Causes
Peripheral vascular resistance and cardiac output are the two main determinants for the presentation of syncope. autonomic nervous system impairment due to drugs or an autonomic failure, can lead to a decrease in peripheral vascular resistance. Reflex activity impairment may also cause a decrease of peripheral vascular resistance, as the body normal compensation reflexes fail. Decrease in cardiac output may be due to venous pooling, cardioinhibitory reflexes, arrhythmia, hypertension, pulmonary embolism, and volume depletion leading to diminished venous return, among others.
Life threatening Causes
Life-threatening causes include conditions which may result in death or permanent disability within 24 hours if left untreated.[1]
- Massive Hemorrhage
- Tamponade
- Bradyarrhythmia
- Massive Pulmonary embolism[2]
- Ruptured abdominal aortic aneurysm
- Ventricular arrhythmia[3]
| Arrhythmia causes of syncope | Cardiovascular non arrhythmia causes of syncope | Non cardiac causes of syncope |
|---|---|---|
|
|
|
Common Causes
Causes by Organ System
Causes in Alphabetical Order
References
- ↑ Shen, Win-Kuang; Sheldon, Robert S.; Benditt, David G.; Cohen, Mitchell I.; Forman, Daniel E.; Goldberger, Zachary D.; Grubb, Blair P.; Hamdan, Mohamed H.; Krahn, Andrew D.; Link, Mark S.; Olshansky, Brian; Raj, Satish R.; Sandhu, Roopinder Kaur; Sorajja, Dan; Sun, Benjamin C.; Yancy, Clyde W. (2017). “2017 ACC/AHA/HRS Guideline for the Evaluation and Management of Patients With Syncope: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society”. Circulation. 136 (5). doi:10.1161/CIR.0000000000000499. ISSN 0009-7322.
- ↑ Prandoni, Paolo; Lensing, Anthonie W.A.; Prins, Martin H.; Ciammaichella, Maurizio; Perlati, Marica; Mumoli, Nicola; Bucherini, Eugenio; Visonà, Adriana; Bova, Carlo; Imberti, Davide; Campostrini, Stefano; Barbar, Sofia (2016-10-20). “Prevalence of Pulmonary Embolism among Patients Hospitalized for Syncope”. New England Journal of Medicine. 375 (16): 1524–1531. doi:10.1056/NEJMoa1602172. ISSN 1533-4406 0028-4793, 1533-4406 Check
|issn=value (help). Retrieved 2016-10-21. - ↑ Khoo, C.; Chakrabarti, S.; Arbour, L.; Krahn, AD. (2013). “Recognizing life-threatening causes of syncope”. Cardiol Clin. 31 (1): 51–66. doi:10.1016/j.ccl.2012.10.005. PMID 23217687. Unknown parameter
|month=ignored (help) - ↑ Kapoor, WN. (2000). “Syncope”. N Engl J Med. 343 (25): 1856–62. doi:10.1056/NEJM200012213432507. PMID 11117979. Unknown parameter
|month=ignored (help) - ↑ Nishida, K.; Hirota, SK.; Tokeshi, J. (2008). “Laugh syncope as a rare sub-type of the situational syncopes: a case report”. J Med Case Rep. 2: 197. doi:10.1186/1752-1947-2-197. PMID 18538031.
- ↑ Benbadis, SR.; Chichkova, R. (2006). “Psychogenic pseudosyncope: an underestimated and provable diagnosis”. Epilepsy Behav. 9 (1): 106–10. doi:10.1016/j.yebeh.2006.02.011. PMID 16697264. Unknown parameter
|month=ignored (help)
Differentiating Syncope from other Diseases

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Karol Gema Hernandez, M.D. [2] Sahar Memar Montazerin, M.D.[3]
Overview
Syncope should be differentiated from other conditions causing partial or complete loss of consciousness. These disorders may include, coma, dizziness, seizure, and vertigo. There are conditions that may mistakenly be diagnosed as syncope. These conditions include epilepsy, hypoglycemia, intoxication, cataplexy, and transient ischemic attacks.
Differentiating Syncope from other Diseases
A quick algorithm to differentiate syncope from other causes of altered mental status is demonstrated below:
| Clinical presentation | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Loss of conscoiusness | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| No | Yes | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| • Transient? • Rapid onset? • Short duration? • Spontaneous recovery? | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Falls | Altered consciousnes | Yes | No | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Coma | Aborted SCD | Others | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
| T-LOC | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Non-Traumatic | Traumatic | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Syncope | Epileptic seizure | Psychogenic | Rare causes | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
| • Reflex syncope • Orthostatic hypotension • Cardiac syncope | • Tonic • Clonic • Tonic-clonic • Atonic | • Pseudo-epileptic • Pseudo-syncopal | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
Abbreviations: SCD: Sudden cardiac death;T-LOC: Transient-Loss of consciousness.
| The above algorithm adopted from ESC guideline [1] |
|---|
Syncope should be differentiated from other conditions causing partial or loss of consciousness. These disorders may include:[2]
| Conditions Incorrectly Diagnosed as Syncope |
|---|
| Disorders with partial or complete loss of consciousness |
|
|
| Conditions without loss of consciousness |
|
|
|
| The above table adopted from ESC guideline [1] |
|---|
Syncope, must be differentiated from other diseases that may cause, altered mental status, motor and or somatosensory deficits. The table below, summarizes the neurologic differential diagnosis for syncope:
| Diseases | History | Symptoms | Physical Examination | Diagnostic tests | Other Findings | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Headache | ↓ LOC | Motor weakness | Abnormal sensory | Motor Deficit | Sensory deficit | Speech difficulty | Gait abnormality | Cranial nerves | CT/MRI | CSF | Gold standard test | |||
| Wernicke’s encephalopathy [3] |
|
– | + | – | – | – | + | + | + | + | – | NA | Clinical assesment and lab findings | |
| Drug toxicity [4][5][6][7] | Medication history of | – | + | – | + | + | + | – | + | – | – | NA | Drug screen test | |
| Metabolic disturbances (electrolyte imbalance, hypoglycemia) [8][9] | – | – | + | + | + | + | + | – | – | + | – | Hypoglycemia, hyponatremia, hypernatremia, hypokalemia, and hyperkalemia | Depends on the cause | |
| Meningitis or encephalitis | + | – | – | – | – | + | + | – | – | – | ↑ Leukocytes, ↑ protein, ↓ glucose | CSF analysis | ||
References
- ↑ 1.0 1.1 Moya, A.; Sutton, R.; Ammirati, F.; Blanc, J.-J.; Brignole, M.; Dahm, J. B.; Deharo, J.-C.; Gajek, J.; Gjesdal, K.; Krahn, A.; Massin, M.; Pepi, M.; Pezawas, T.; Granell, R. R.; Sarasin, F.; Ungar, A.; van Dijk, J. G.; Walma, E. P.; Wieling, W.; Abe, H.; Benditt, D. G.; Decker, W. W.; Grubb, B. P.; Kaufmann, H.; Morillo, C.; Olshansky, B.; Parry, S. W.; Sheldon, R.; Shen, W. K.; Vahanian, A.; Auricchio, A.; Bax, J.; Ceconi, C.; Dean, V.; Filippatos, G.; Funck-Brentano, C.; Hobbs, R.; Kearney, P.; McDonagh, T.; McGregor, K.; Popescu, B. A.; Reiner, Z.; Sechtem, U.; Sirnes, P. A.; Tendera, M.; Vardas, P.; Widimsky, P.; Auricchio, A.; Acarturk, E.; Andreotti, F.; Asteggiano, R.; Bauersfeld, U.; Bellou, A.; Benetos, A.; Brandt, J.; Chung, M. K.; Cortelli, P.; Da Costa, A.; Extramiana, F.; Ferro, J.; Gorenek, B.; Hedman, A.; Hirsch, R.; Kaliska, G.; Kenny, R. A.; Kjeldsen, K. P.; Lampert, R.; Molgard, H.; Paju, R.; Puodziukynas, A.; Raviele, A.; Roman, P.; Scherer, M.; Schondorf, R.; Sicari, R.; Vanbrabant, P.; Wolpert, C.; Zamorano, J. L. (2009). “Guidelines for the diagnosis and management of syncope (version 2009): The Task Force for the Diagnosis and Management of Syncope of the European Society of Cardiology (ESC)”. European Heart Journal. 30 (21): 2631–2671. doi:10.1093/eurheartj/ehp298. ISSN 0195-668X.
- ↑ Task Force for the Diagnosis and Management of Syncope. European Society of Cardiology (ESC). European Heart Rhythm Association (EHRA). Heart Failure Association (HFA). Heart Rhythm Society (HRS). Moya A; et al. (2009). “Guidelines for the diagnosis and management of syncope (version 2009)”. Eur Heart J. 30 (21): 2631–71. doi:10.1093/eurheartj/ehp298. PMC 3295536. PMID 19713422.
- ↑ Thomson, Allan D.; Marshall, E. Jane (2006). “THE NATURAL HISTORY AND PATHOPHYSIOLOGY OF WERNICKE’S ENCEPHALOPATHY AND KORSAKOFF’S PSYCHOSIS”. Alcohol and Alcoholism. 41 (2): 151–158. doi:10.1093/alcalc/agh249. ISSN 1464-3502.
- ↑ Hedya SA, Avula A, Swoboda HD. PMID 29763168. Missing or empty
|title=(help) - ↑ Iorga A, Horowitz BZ. PMID 29494051. Missing or empty
|title=(help) - ↑ Hamed, Sherifa A (2017). “The auditory and vestibular toxicities induced by antiepileptic drugs”. Expert Opinion on Drug Safety. 16 (11): 1281–1294. doi:10.1080/14740338.2017.1372420. ISSN 1474-0338.
- ↑ Brostoff, J. M.; Birns, J.; McCrea, D. (2008). “Phenytoin toxicity: an easily missed cause of cerebellar syndrome”. Journal of Clinical Pharmacy and Therapeutics. 33 (2): 211–214. doi:10.1111/j.1365-2710.2008.00903.x. ISSN 0269-4727.
- ↑ Giuliani, Corinna; Peri, Alessandro (2014). “Effects of Hyponatremia on the Brain”. Journal of Clinical Medicine. 3 (4): 1163–1177. doi:10.3390/jcm3041163. ISSN 2077-0383.
- ↑ Witsch, Jens; Neugebauer, Hermann; Flechsenhar, Julia; Jüttler, Eric (2012). “Hypoglycemic encephalopathy: a case series and literature review on outcome determination”. Journal of Neurology. 259 (10): 2172–2181. doi:10.1007/s00415-012-6480-z. ISSN 0340-5354.
Epidemiology and Demographics
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Sahar Memar Montazerin, M.D.[2]
Overview
The incidence of syncope ranges from 260 to 1950 cases per 100,000 individuals worldwide. It increases with age and especially after age 70 years old. Syncope affects men and women equally.
Epidemiology and Demographics
Incidence
Age
- The incidence of syncope increase with age and especially after age 70 years old.[2]
- The incidence peaks around age 20 and 80 years old.
Gender
- Syncope affects men and women equally.[1]
References
- ↑ 1.0 1.1 Soteriades, Elpidoforos S.; Evans, Jane C.; Larson, Martin G.; Chen, Ming Hui; Chen, Leway; Benjamin, Emelia J.; Levy, Daniel (2002). “Incidence and Prognosis of Syncope”. New England Journal of Medicine. 347 (12): 878–885. doi:10.1056/NEJMoa012407. ISSN 0028-4793.
- ↑ 2.0 2.1 Ruwald, M. H.; Hansen, M. L.; Lamberts, M.; Hansen, C. M.; Hojgaard, M. V.; Kober, L.; Torp-Pedersen, C.; Hansen, J.; Gislason, G. H. (2012). “The relation between age, sex, comorbidity, and pharmacotherapy and the risk of syncope: a Danish nationwide study”. Europace. 14 (10): 1506–1514. doi:10.1093/europace/eus154. ISSN 1099-5129.
Risk Factors
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Sahar Memar Montazerin, M.D.[2] Sara Zand, M.D.[3]
Overview
Syncope is a sign of insufficient cerebral blood flow and it should be evaluated for the underlying cause. Possible underlying risk factors of cardiac syncope include older age (>60 y), male sex, presence of known ischemic heart disease, structural heart disease, previous arrhythmias, or reduced ventricular function, brief prodromes such as palpitations or sudden loss of consciousness without a prodrome, syncope during exertion, syncope in the supine position, low number of syncope episodes (1 or 2), abnormal cardiac examination, family history of inheritable conditions or premature sudden cardiac death (SCD) (<50 y of age), or presence of known congenital heart disease. Common risk factors associated with noncardiac causes of syncope include younger age, no known cardiac disease, syncope only in the standing position, positional change from supine or sitting to standing, presence of prodrome: nausea, vomiting, feeling warm, presence of specific triggers ||||( dehydration, pain, stressful stimulus, medical environment), situational triggers( cough, laugh, micturition, defecation, deglutition), history of syncope with similar characteristics and frequent recurrence
Risk Factors
- Common risk factors associated with cardiac causes of syncope include:[1]
- Older age (>60 y)
- Male sex
- Presence of known ischemic heart disease, structural heart disease, previous arrhythmias, or reduced ventricular function
- Brief prodromes, such as palpitations, or sudden loss of consciousness without a prodrome
- Syncope during exertion
- Syncope in the supine position
- Low number of syncope episodes (1 or 2)
- Abnormal cardiac examination
- Family history of inheritable conditions or premature sudden cardiac death (SCD) (<50 y of age)
- Presence of known congenital heart disease
- Common risk factors associated with noncardiac causes of syncope include:
- Younger age
- No known cardiac disease
- Syncope only in the standing position
- Positional change from supine or sitting to standing
- Presence of prodrome: nausea, vomiting, feeling warmth
- Presence of specific triggers: dehydration, pain, stressful stimulus, medical environment
- Situational triggers: cough, laugh, micturition, defecation, deglutition
- History of syncope with similar characteristics and frequent recurrence
- Short term risk factors associated with the outcomes of syncope in the emergency department until 30 days after event include:
- Male sex
- Older age (>60 y)
- No prodrome
- Palpitation preceding loss of consciousness
- Exertional syncope
- Structural heart disease
- Heart failure
- Cerebrovascular disease
- Family history of SCD
- Trauma
- Physical Examination or Laboratory Investigation
- Evidence of bleeding
- Persistent abnormal vital signs
- Abnormal ECG
- Positive troponin
- Long term risk factors associated with the outcomes of syncope > 30 days until one year after event include:
- Male sex
- Older age
- Absence of nausea/vomiting preceding syncopal event
- Ventricular arrhythmia
- Cancer
- Structural heart disease
- Heart failure
- Cerebrovascular disease
- Diabetes mellitus
- Physical Examination or Laboratory Investigation
- Abnormal ECG
- Lower GFR
- High CHADS score ( congestive heart failure, hypertension, age ≥75 years, diabetes mellitus, stroke or transient ischemic attack)
- The following factors have been associated with increased risk of orthostatic syncope:[2]
- Sudden postural change of the head (especially upon waking in the morning)
- Standing still for a long period
- Certain antihypertensive drugs (e.g., diuretics, vasodilators)
- Severe exertion with dehydration
- Reduced “thirst drive” in elderly individuals
- Avoidance of fluid intake in older men (to minimize prostate symptoms)
- Excess alcohol or caffeine use
- Straining during micturition or defecation
- High environmental temperature (including hot baths, showers, and saunas)
- Large meals (especially with refined carbohydrates)
References
- ↑ . doi:10.1161/CIR.0000000000000499Circulation. Missing or empty
|title=(help) - ↑ Anil, OmMurti (2016). “Syncope: Approach to diagnosis”. Journal of Clinical and Preventive Cardiology. 5 (3): 84. doi:10.4103/2250-3528.191099. ISSN 2250-3528.
Natural History, Complications and Prognosis
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Sara Zand, M.D.[2] Sahar Memar Montazerin, M.D.[3]
Overview
Patients with syncope are at risk of the development of complications, such as trauma from frequent falls and Sudden cardiac death. The prognosis of syncope depends on underlying causes. Syncope caused by cardiovascular diseases may be life-threatening and is an important cause of sudden cardiac death. Prognosis of vasovagal syncope is favorable.
Natural history, Complications and Prognosis
Natural History
If the underlying cause of syncope is left untreated and syncope occurs frequently, patients with syncope may suffer from trauma of the head and neck and sudden cardiac death due to fatal cardiac arrhythmia.
Complications
Patients with syncope are at risk of the development of the following complications:[17]
- Frequent falls resulting in injuries to head and neck
- Development of cardiovascular disorders
- Sudden cardiac death
- Death
Prognosis
The prognosis of syncope depends on underlying causes.[18][19]
- Syncope caused by cardiovascular diseases may be life-threatening and is an important cause of sudden cardiac death.
- Prognosis of vasovagal syncope is favorable.
References
- ↑ . doi:10.2169/internalmedicine.52.8818. Check
|doi=value (help). Missing or empty|title=(help) - ↑ Vasquez, Andres F.; Seger, John J. (2009). “An Uncommon Case of Heart Failure”. Southern Medical Journal. 102 (11): 1183–1185. doi:10.1097/SMJ.0b013e3181b63b1c. ISSN 0038-4348.
- ↑ Rovetta R, Bonadei I, Vizzardi E, D’Aloia A, Metra M (August 2014). “Syncope as presentation of recurrent Tako-Tsubo cardiomyopathy”. Minerva Cardioangiol. 62 (4): 366–8. PMID 25012104.
- ↑ Prandoni P, Lensing AW, Prins MH, Ciammaichella M, Perlati M, Mumoli N, Bucherini E, Visonà A, Bova C, Imberti D, Campostrini S, Barbar S (October 2016). “Prevalence of Pulmonary Embolism among Patients Hospitalized for Syncope”. N Engl J Med. 375 (16): 1524–1531. doi:10.1056/NEJMoa1602172. PMID 27797317.
- ↑ Strobel JS, Fuisz AR, Epstein AE, Plumb VJ (October 1999). “Syncope and inducible ventricular fibrillation in a woman with hemochromatosis”. J Interv Card Electrophysiol. 3 (3): 225–9. doi:10.1023/a:1009891406964. PMID 10490478.
- ↑ Akashi R, Kizaki Y, Kawano H, Takahara Y, Nakao K, Yonemitsu N, Kusumoto S, Maemura K (2012). “Seizures and syncope due to complete atrioventricular block in a patient with acute myocarditis with a normal left ventricular systolic function”. Intern Med. 51 (21): 3035–40. doi:10.2169/internalmedicine.51.8410. PMID 23124146.
- ↑ Ciesielski CA, Markowitz LE, Horsley R, Hightower AW, Russell H, Broome CV (1989). “Lyme disease surveillance in the United States, 1983-1986”. Rev Infect Dis. 11 Suppl 6: S1435–41. PMID 2682955.
- ↑ . doi:10.1016/j.amjcard.2008.12.013. Check
|doi=value (help). Missing or empty|title=(help) - ↑ Perryman RA, Bayne E, Miller RH (April 1991). “Bull-worker syncope: congenital subclavian steal syndrome following isometric exercise”. Pediatr Cardiol. 12 (2): 105–6. doi:10.1007/BF02238413. PMID 1866327.
- ↑ Squarzoni G, Bariani L, Fogli B, Ughi M, Manfredini R, Fersini C (1991). “[Arterial hypertension and syncope in an adult patient with coarctation of the aorta]”. Riv Eur Sci Med Farmacol (in Italian). 13 (1–2): 33–5. PMID 1796194.
- ↑ Kremastinos DT, Farmakis D, Aessopos A, Hahalis G, Hamodraka E, Tsiapras D, Keren A (May 2010). “Beta-thalassemia cardiomyopathy: history, present considerations, and future perspectives”. Circ Heart Fail. 3 (3): 451–8. doi:10.1161/CIRCHEARTFAILURE.109.913863. PMID 20484195.
- ↑ Reynen K (December 1995). “Cardiac myxomas”. N Engl J Med. 333 (24): 1610–7. doi:10.1056/NEJM199512143332407. PMID 7477198.
- ↑ Monté CP, de Krom MC, Weber WE, de Zwaan C, van Kranen-Mastenbroek VH (March 2007). “The ictal bradycardia syndrome”. Acta Neurol Belg. 107 (1): 22–5. PMID 17569230.
- ↑ Ahern M, Lever JV, Cosh J (August 1983). “Complete heart block in rheumatoid arthritis”. Ann Rheum Dis. 42 (4): 389–97. doi:10.1136/ard.42.4.389. PMC 1001249. PMID 6882034.
- ↑ Silber H, Khan SS, Matloff JM, Chaux A, DeRobertis M, Gray R (January 1993). “The St. Jude valve. Thrombolysis as the first line of therapy for cardiac valve thrombosis”. Circulation. 87 (1): 30–7. doi:10.1161/01.cir.87.1.30. PMID 8419020.
- ↑ Velazquez-Ceceña JL, Lubell DL, Nagajothi N, Al-Masri H, Siddiqui M, Khosla S (2009). “Syncope from dynamic left ventricular outflow tract obstruction simulating hypertrophic cardiomyopathy in a patient with primary AL-type amyloid heart disease”. Tex Heart Inst J. 36 (1): 50–4. PMC 2676515. PMID 19436787.
- ↑ Auer, J. (2008). “Syncope and trauma. Are syncope-related traumatic injuries the key to find the specific cause of the symptom?”. European Heart Journal. 29 (5): 576–578. doi:10.1093/eurheartj/ehm637. ISSN 0195-668X.
- ↑ Soteriades, Elpidoforos S.; Evans, Jane C.; Larson, Martin G.; Chen, Ming Hui; Chen, Leway; Benjamin, Emelia J.; Levy, Daniel (2002). “Incidence and Prognosis of Syncope”. New England Journal of Medicine. 347 (12): 878–885. doi:10.1056/NEJMoa012407. ISSN 0028-4793.
- ↑ Saklani, Pradyot; Krahn, Andrew; Klein, George (2013). “Syncope”. Circulation. 127 (12): 1330–1339. doi:10.1161/CIRCULATIONAHA.112.138396. ISSN 0009-7322.
Diagnosis
Diagnosis
History and Symptoms | Physical Examination | Laboratory Findings | Electrocardiogram | CT | MRI | Echocardiography | Other Imaging Findings | Other Diagnostic Studies
Treatment
Treatment
Medical Therapy | Surgery | Primary Prevention | Secondary Prevention | Cost-Effectiveness of Therapy | Future or Investigational Therapies
Related Chapters
Related Chapters
Template:Skin and subcutaneous tissue symptoms and signs Template:Nervous and musculoskeletal system symptoms and signs Template:Urinary system symptoms and signs Template:Cognition, perception, emotional state and behaviour symptoms and signs Template:Speech and voice symptoms and signs Template:General symptoms and signs
Looking for the patient version?
© 2026 MyEClinic – IFTM Institut für Telematik in der Medizin GmbH
